Suicide
Conditions
Keywords
Social network, Website
Brief summary
The Electronic Youth-Nominated Support Team (eYST), is experimental. The purpose of this study is to get feedback from users about eYST. Another purpose of this study is to learn how well eYST helps youth.
Detailed description
Assessment data from multiple stakeholders (i.e., youth, parents, and support adults) will be collected at baseline, 4 weeks, 8 weeks, and 12 weeks via self-report and semi-structured interviews. A request to extend the record's NIH results reporting deadline to November 1, 2025 was submitted in a timely manner prior to October-November 2025 government shutdown. This request was approved retroactively once the shutdown ended on November 12. During the shutdown, the record was locked and could not be edited by the Responsible Party. Results were submitted as soon as possible upon the unlocking of the record.
Interventions
The website is a psychoeducational, social support program for adolescents at risk for suicide
Sponsors
Study design
Eligibility
Inclusion criteria
1. Inpatient psychiatric patients who have attempted suicide or have documented Suicide ideation (SI) and a plan to harm themselves at admission. 2. Understand written and spoken English. 3. Own a smartphone or mobile phone. 4. Willing and able to complete enrollment procedures. 5. Parent or guardian and youth able to understand the nature of the study and provide written informed consent and assent for youth 6. Patients who are able to provide at least one verifiable contact for emergency or tracking purposes.
Exclusion criteria
1. Patients with active psychosis. 2. Patients experiencing substance withdrawal. 3. Currently enrolled in other treatment studies for the symptoms and behaviors targeted. 4. Patient unwilling or unable to wear a mask during in person study procedures, if mandated due to current COVID/health safety guidelines. 5. Patients who in the judgment of the investigator would have an unfavorable risk or benefit profile with respect to eYST. 6. Any other psychiatric or medical condition or custody arrangement that in the investigators' opinion would preclude informed consent or assent or participation in the trial.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Duration of Use of App - Adult Support Participants | Weeks 1, 4, 8, and 12 | Website usage metrics were captured by measuring the duration of website use by by support adults. |
| System Usability Scale (SUS) Score - Youth Participants | At 4 Weeks | 10-item measure. Scores ranged from 0 to 100. The researchers calculated the mean score. A mean score of 68 was the minimal indicator of usability. Results reflect data from Youth Participants. |
| System Usability Scale (SUS) Score - Adult Caregiver Participants | At 4 Weeks | 10-item measure. Scores ranged from 0 to 100. The researchers calculated the mean score. A mean score of 68 was the minimal indicator of usability. Results reflect data from Adult Caregiver Participants. |
| System Usability Scale (SUS) Score - Adult Support Participants | At 8 Weeks | 10-item measure. Scores ranged from 0 to 100. The researchers calculated the mean score. A mean score of 68 was the minimal indicator of usability. Results reflect data from Adult Support Participants. |
| Frequency of Use of App - Youth Participants | Weeks 1, 4, 8, and 12 | Website usage metrics were captured by counting the number of website log-ins by Youth (adolescent) Participants. |
| Frequency of Use of App - Adult Caregiver Participants | Weeks 1, 4, 8, and 12 | Website usage metrics were captured by counting the number of website log-ins by parents/caregivers. |
| Frequency of Use of App - Adult Support Participants | Week 1, 4, 8, 12 | Website usage metrics were captured by counting the number of website log-ins by supporting adults. |
| Duration of Use of App - Youth Participants | Weeks 1, 4, 8, and 12 | Website usage metrics were captured by measuring the duration of website use by adolescents. |
| Duration of Use of App - Adult Caregiver Participants | Weeks 1, 4, 8, and 12 | Website usage metrics were captured by measuring the duration of website use by parents/caregivers. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of Intervention Measure (FIM) - Youth Participants | At 4 Weeks | Items were scored on a 5-point scale ranging from 1 to 5 (completely disagree to completely agree). Higher scores indicated higher perceived intervention feasibility. Results reflect data from Youth Participants. |
| Feasibility of Intervention Measure (FIM) - Adult Caregiver Participants | At 4 Weeks | Items were scored on a 5-point scale ranging from 1 to 5 (completely disagree to completely agree). Higher scores indicated higher perceived intervention feasibility. Results reflect data from Adult Caregiver Participants. |
| Feasibility of Intervention Measure (FIM) - Adult Support Participants | At 8 Weeks | Items were scored on a 5-point scale ranging from 1 to 5 (completely disagree to completely agree). Higher scores indicated higher perceived intervention feasibility. Results reflect data from Adult Support Participants. |
| Acceptability of Intervention Measure (AIM) - Youth Participants | At 4 Weeks | Items were scored on a 5-point scale ranging from 1 to 5 (completely disagree to completely agree). Higher scores indicated higher acceptability. Results reflect data from Youth Participants. |
| Acceptability of Intervention Measure (AIM) - Adult Caregiver Participants | At 4 Weeks | Items were scored on a 5-point scale ranging from 1 to 5 (completely disagree to completely agree). Higher scores indicated higher acceptability. Results reflect data from Adult Caregiver Participants. |
| Acceptability of Intervention Measure (AIM) - Adult Support Participants | At 8 Weeks | Items were scored on a 5-point scale ranging from 1 to 5 (completely disagree to completely agree). Higher scores indicated higher acceptability. Results reflect data from Adult Support Participants. |
| Intervention Appropriateness Measure (IAM) - Youth Participants | At 4 Weeks | Items were scored on a 5-point scale ranging from 1 to 5 (completely disagree to completely agree). Higher scores indicated higher perceived intervention appropriateness. Results reflect data from Youth Participants. |
| Intervention Appropriateness Measure (IAM) - Adult Caregiver Participants | At 4 Weeks | Items were scored on a 5-point scale ranging from 1 to 5 (completely disagree to completely agree). Higher scores indicated higher perceived intervention appropriateness. Results reflect data from Adult Caregiver Participants. |
| Intervention Appropriateness Measure (IAM) - Adult Support Participants | At 8 Weeks | Items were scored on a 5-point scale ranging from 1 to 5 (completely disagree to completely agree). Higher scores indicated higher perceived intervention appropriateness. Results reflect data from Adult Support Participants. |
| Client Satisfaction Questionnaire (CSQ-I) - Youth Participants | At 4 Weeks | The CSQ-I was a valid and reliable scale for measuring overall satisfaction with health and human services, including digital or internet-based intervention. This was adapted for use with youth, parents, and support adults. The adapted scales each had 8 items in a Likert scale ranging from 8-32 where higher numbers indicated higher satisfaction. Results reflect data from Youth Participants. |
| Client Satisfaction Questionnaire (CSQ-I) - Adult Caregiver Participants | At 4 Weeks | The CSQ-I was a valid and reliable scale for measuring overall satisfaction with health and human services, including digital or internet-based intervention. This was adapted for use with youth, parents, and support adults. The adapted scales each had 8 items in a Likert scale ranging from 8-32 where higher numbers indicated higher satisfaction. Results reflect data from Adult Caregiver Participants. |
| Client Satisfaction Questionnaire (CSQ-I) - Adult Support Participants | At 8 Weeks | The CSQ-I was a valid and reliable scale for measuring overall satisfaction with health and human services, including digital or internet-based intervention. This was adapted for use with youth, parents, and support adults. The adapted scales each had 8 items in a Likert scale ranging from 8-32 where higher numbers indicated higher satisfaction. Results reflect data from Adult Support Participants. |
Countries
United States
Contacts
University of Michigan
Oui Therapeutics, Inc.
Participant flow
Recruitment details
Participants were youths and one of their primary caregivers. In order to proceed to the trial, the caregiver had to consent, and the youth had to assent.
Pre-assignment details
Data could be collected from either youth or parent participants, even if their corresponding adult or youth did not respond at a given time point.
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Continuous | 36 years STANDARD_DEVIATION 15.94 |
| Race/Ethnicity, Customized Hispanic or Latino | 7 Participants |
| Race/Ethnicity, Customized Not Hispanic or Latino | 14 Participants |
| Race/Ethnicity, Customized Prefer Not to Answer | 0 Participants |
| Race/Ethnicity, Customized Unknown | 3 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 1 Participants |
| Race (NIH/OMB) More than one race | 1 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 65 Participants |
| Region of Enrollment Spain | 0 Participants |
| Region of Enrollment United States | 19 Participants |
| Sex: Female, Male Female | 9 Participants |
| Sex: Female, Male Male | 21 Participants |
| Sex/Gender, Customized Data Missing | 0 Participants |
| Sex/Gender, Customized Female | 47 Participants |
| Sex/Gender, Customized Gender Queer/Gender Nonconforming | 1 Participants |
| Sex/Gender, Customized Male | 1 Participants |
| Sex/Gender, Customized Other/Not Listed Above | 0 Participants |
| Sex/Gender, Customized Prefer not to answer | 0 Participants |
| Sex/Gender, Customized Trans Female/Trans Girl | 0 Participants |
| Sex/Gender, Customized Trans Male/Trans Boy | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 19 |
| other Total, other adverse events | 0 / 19 |
| serious Total, serious adverse events | 2 / 19 |